Acumen Pharmaceuticals (ABOS)

• Market cap: $169M
• 1 day: -0.71%
• 5 days: 40.91%
• 1 month: 39.5%
• 3 months: 23.45%
• 6 months: 102.17%
• Year to date: 38.12%
• 1 year: 77.71%
• 5 years: -86.12%
• 10 years: -86.12%
• Sector: Healthcare
• Industry: Biotechnology

About: Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Employees: 52